Company
United StatesPublic company, NYSE: MDTMedtronic Inc (NYSE: MDT), West Des Moines, IA – FDA Inspections
Inspection records and compliance data for Medtronic Inc in West Des Moines, Iowa. 2 FDA inspections on record, last inspected December 02, 2014. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic Inc based in West Des Moines, Iowa, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected November 6, 2012. Last inspected December 2, 2014.
Most cited issue areas
- Procedures and release criteria1 inspection
- Records maintained concurrently1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 2, 2014 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 905394 |
| November 6, 2012 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 805546 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Medtronic Inc
Stock ticker
MDT
Exchange
NYSE
Share price
$105.03
Market cap
$134.3B
Price as of
November 6, 2026
FEI Number
3009389821
Address
1501 42nd St Ste 350, West Des Moines, Iowa 50266, United States
Country
United States
ID: fca7185a-e917-4f50-beee-139000e7d964